Main content area

Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease

Naji, DuraidHamid, Tan, Chengcheng, Han, Fabin, Zhao, Yuanyuan, Wang, Junhan, Wang, Dan, Fa, Jingjing, Li, Sisi, Chen, Shanshan, Chen, Qiuyun, Xu, Chengqi, Wang, QingK.
Molecular genetics and genomics 2018 v.293 no.1 pp. 119-128
blood coagulation, coagulation, coronary artery disease, fibrinogen, genes, genomics, models, patients, proteinase inhibitors, prothrombin, risk, thrombin, thromboplastin, transcriptional activation
The tissue factor pathway inhibitor (TFPI) gene encodes a protease inhibitor with a critical role in regulation of blood coagulation. Some genomic variants in TFPI were previously associated with plasma TFPI levels, however, it remains to be further determined whether TFPI variants are associated with other coagulation factors. In this study, we carried out a large population-based study with 2313 study subjects for blood coagulation data, including fibrinogen levels, prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT). We identified significant association of TFPI variant rs10931292 (a functional promoter variant with reduced transactivation) with increased plasma fibrinogen levels (P = 0.017 under a recessive model), but not with PT, APTT or TT (P > 0.05). Using a large case–control association study population with 4479 CAD patients and 3628 controls, we identified significant association between rs10931292 and CAD under a recessive model (OR 1.23, P = 0.005). For the first time, we show that a TFPI variant is significantly associated with fibrinogen levels and risk of CAD. Our finding contributes significantly to the elucidation of the genetic basis and biological pathways responsible for fibrinogen levels and development of CAD.